Abstract
Designing ontology to represent gene function is of vital importance for meeting the major challenge of integrating sequence data with the increasing amount of data from functional analyses of genes. Given that genes are expressed in temporally and spatially characteristic patterns, their products quite often reside in specific cellular compartments and may be part of one or more multi-component complexes. Genes may have more than one product and the products are functionally distinct. An overall strategy elucidating how an ontology-based gene function may be implemented using genomic databases is herein dissected. Knowing that gene products possess one or more biochemical, physiological or structural functions, the present strategy is suggested to lead towards physiological models. A review of the features of the currently available software tools for the implementation of the considered strategy is presented.
Keywords: Database, functional genomics, gene expression, gene ontology, physiology, systems biology, Model Structure Markup Language, physiology, cellular component ontology, International Nucleotide Sequence Database Collaboration
Current Bioinformatics
Title:From Ontology-Based Gene Function to Physiological Model
Volume: 7 Issue: 4
Author(s): Ajay Shiv Sharma, Hari Om Gupta and Petar M. Mitrasinovic
Affiliation:
Keywords: Database, functional genomics, gene expression, gene ontology, physiology, systems biology, Model Structure Markup Language, physiology, cellular component ontology, International Nucleotide Sequence Database Collaboration
Abstract: Designing ontology to represent gene function is of vital importance for meeting the major challenge of integrating sequence data with the increasing amount of data from functional analyses of genes. Given that genes are expressed in temporally and spatially characteristic patterns, their products quite often reside in specific cellular compartments and may be part of one or more multi-component complexes. Genes may have more than one product and the products are functionally distinct. An overall strategy elucidating how an ontology-based gene function may be implemented using genomic databases is herein dissected. Knowing that gene products possess one or more biochemical, physiological or structural functions, the present strategy is suggested to lead towards physiological models. A review of the features of the currently available software tools for the implementation of the considered strategy is presented.
Export Options
About this article
Cite this article as:
Shiv Sharma Ajay, Om Gupta Hari and M. Mitrasinovic Petar, From Ontology-Based Gene Function to Physiological Model, Current Bioinformatics 2012; 7 (4) . https://dx.doi.org/10.2174/157489312803901054
DOI https://dx.doi.org/10.2174/157489312803901054 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recombinant Protein Based Therapeutics for IPF
Inflammation & Allergy - Drug Targets (Discontinued) Cytotoxic, Apoptotic and DNA Synthesis Inhibitory Effects of Some Thiazole Derivatives
Letters in Drug Design & Discovery Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology
Current Drug Metabolism Recent Advances in Hematopoietic Stem Cell-Mediated Regeneration
Recent Patents on Regenerative Medicine Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A
Current Cancer Drug Targets Cationized Albumin Conjugated Solid Lipid Nanoparticles as Vectors for Brain Delivery of an Anti-Cancer Drug
Current Nanoscience Nandrolone Decanoate Enhances the Activities of Cholanthrene Induced Glutathione-s-Transferase in Liver Tissue of Albino Mice
Drug Metabolism Letters In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Anti-Cancer Agents in Medicinal Chemistry Chemical Advances in Therapeutic Application of Exosomes and Liposomes
Current Medicinal Chemistry Engineered Inorganic/Organic-Core/Shell Magnetic Fe<sub>x</sub>O<sub>y</sub> Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents
Current Pharmaceutical Design Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma
Current Cancer Therapy Reviews Late Life Depression: A Diagnostic and Pharmacological Review
Current Psychopharmacology Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Current Cancer Drug Targets Restoring p53 Function in Cancer: Novel Therapeutic Approaches for Applying the Brakes to Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery MicroRNA-16-5p Controls Development of Osteoarthritis by Targeting SMAD3 in Chondrocytes
Current Pharmaceutical Design Investigation of <i>ACE rs4646994, MTHFR rs1801133</i> and <i>VDR rs2228570</i> Genotypes in Jordanian Patients with Fibromyalgia Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Ascorbic Acid: An Old Player with a Broad Impact on Body Physiology Including Oxidative Stress Suppression and Immunomodulation: A Review
Mini-Reviews in Medicinal Chemistry ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology